A Deep Dive: Understanding the Neurological Toll of Long COVID

Ravindra Ganesh, MD, MBBS, FACP, Dip ABOM, Svetlana Blitshteyn, MD, FAAN, and Monica Verduzco-Gutierrez, MD, discuss Long COVID's prevalence—noting that 1 in 5 Americans and 1 in 10 patients post-COVID may be affected.

Contagion and NeurologyLive Present: Long COVID Roundtable
Latest Videos

Conference Coverage

View All
The NanoVax Vaccine Platform: Pandemic Preparedness and the Role of Mucosal Immunity
The NanoVax Vaccine Platform: Pandemic Preparedness and the Role of Mucosal Immunity

November 13th 2024

Rebuilding Trust in Intranasal Vaccines for Avian Flu and Other Respiratory Diseases
Rebuilding Trust in Intranasal Vaccines for Avian Flu and Other Respiratory Diseases

November 12th 2024

Long-Acting Lenacapavir Shows Efficacy in Heavily Treatment-Experienced Patients
Long-Acting Lenacapavir Shows Efficacy in Heavily Treatment-Experienced Patients

November 11th 2024

Gilead and Merck Report Successful Phase 2 Results for Investigational Once-Weekly HIV Treatment
Gilead and Merck Report Successful Phase 2 Results for Investigational Once-Weekly HIV Treatment

November 11th 2024

Video Series

Latest News

© 2025 MJH Life Sciences

All rights reserved.